Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Andrés F. Lasave, Ariel Schlaen, David G. Zeballos, Manuel Díaz-Llopis, Cristóbal Couto, Wael M. El-Haig & J. Fernando Arevalo. (2019) Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema. Ocular Immunology and Inflammation 27:2, pages 294-302.
Read now
Read now
Wajiha J. Kheir, Carl-Joe Mehanna, Maamoun Abdul Fattah, Sara Al Ghadban, Marwan El Sabban, Ahmad M. Mansour & Rola N. Hamam. (2018) Intravitreal Adalimumab for the Control of Breakthrough Intraocular Inflammation. Ocular Immunology and Inflammation 26:8, pages 1206-1211.
Read now
Read now
Laura R. Steeples, Nitin Anand, Jiten Moraji & Nicholas P. Jones. (2018) Clinical Outcomes of Intravitreal Preservative-Free Triamcinolone Preparation (Triesence®) for Cystoid Macular Oedema and Inflammation in Patients with Uveitis. Ocular Immunology and Inflammation 26:7, pages 997-1004.
Read now
Read now
Ashvini K. Reddy, Bryn M. Burkholder, Irfan R. Khan & Jennifer E. Thorne. (2018) Iluvien Implantation for Uveitis and Uveitic Macular Edema. Ocular Immunology and Inflammation 26:2, pages 315-316.
Read now
Read now
Hui Yi Tan, Aniruddha Agarwal, Cecilia S Lee, Jay Chhablani, Vishali Gupta, Manoj Khatri, Jayabalan Nirmal, Carlos Pavesio & Rupesh Agrawal. (2016) Management of noninfectious posterior uveitis with intravitreal drug therapy. Clinical Ophthalmology 10, pages 1983-2020.
Read now
Read now
Erol Coşkun, Pelin Celemler, Gezmis Kimyon, Veysi Öner, Bunyamin Kisacik, Ibrahim Erbagci & Ahmet Mesut Onat. (2015) Intravitreal Dexamethasone Implant for Treatment of Refractory Behçet Posterior Uveitis: One-year Follow-up Results. Ocular Immunology and Inflammation 23:6, pages 437-443.
Read now
Read now
Shlomit Schaal, Shivani V Reddy & Henry J Kaplan. (2015) Current medical and surgical therapeutic approaches to cystoid macular edema in uveitis. Expert Review of Ophthalmology 10:1, pages 49-58.
Read now
Read now
Articles from other publishers (16)
Biao Li, Haoran Li, Qun Huang & Yanlin Zheng. (2023) Optimizing glucocorticoid therapy for Behçet's uveitis: efficacy, adverse effects, and advances in combination approaches. International Ophthalmology.
Crossref
Crossref
Lianna M. Valdes & Lucia Sobrin. (2020) Uveitis Therapy: The Corticosteroid Options. Drugs 80:8, pages 765-773.
Crossref
Crossref
Yılmaz Özyazgan & Ilknur Tugal-Tutkun. 2020. Behçet Syndrome. Behçet Syndrome
51
71
.
T. A. Lisitsyna, Z. S. Alekberova & R. G. Goloeva. (2019) New guidelines for the management of patients with Behcet's disease/syndrome (EULAR, 2018). Rheumatology Science and Practice 57:2, pages 133-141.
Crossref
Crossref
Xia Ni Wu & Lyndell Lim. 2019. Treatment of Non-infectious Uveitis. Treatment of Non-infectious Uveitis
157
177
.
Ashleigh Laurin Levison. 2019. Posterior Uveitis. Posterior Uveitis
159
174
.
Yesim Ozguler, Pietro Leccese, Robin Christensen, Sinem Nihal Esatoglu, Dongsik Bang, Bahram Bodaghi, Aykut Ferhat Çelik, Farida Fortune, Julien Gaudric, Ahmet Gul, Ina Kötter, Alfred Mahr, Robert J Moots, Jutta Richter, David Saadoun, Carlo Salvarani, Francesco Scuderi, Petros P Sfikakis, Aksel Siva, Miles Stanford, Ilknur Tugal-Tutkun, Richard West, Sebahattin Yurdakul, Ignazio Olivieri, Hasan Yazici & Gulen Hatemi. (2018) Management of major organ involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations. Rheumatology 57:12, pages 2200-2212.
Crossref
Crossref
Gulen Hatemi, Robin Christensen, Dongsik Bang, Bahram Bodaghi, Aykut Ferhat Celik, Farida Fortune, Julien Gaudric, Ahmet Gul, Ina Kötter, Pietro Leccese, Alfred Mahr, Robert Moots, Yesim Ozguler, Jutta Richter, David Saadoun, Carlo Salvarani, Francesco Scuderi, Petros P Sfikakis, Aksel Siva, Miles Stanford, Ilknur Tugal-Tutkun, Richard West, Sebahattin Yurdakul, Ignazio Olivieri & Hasan Yazici. (2018) 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Annals of the Rheumatic Diseases, pages annrheumdis-2018-213225.
Crossref
Crossref
KunalKaushik Shah, ParthopratimDutta Majumder & Jyotirmay Biswas. (2018) Intravitreal therapeutic agents in noninfectious uveitic macular edema. Indian Journal of Ophthalmology 66:8, pages 1060.
Crossref
Crossref
Esra Sahli & Ozlem Gurbuz-Koz. 2017. Behcet's Disease. Behcet's Disease.
Shih-Chou Chen & Shwu-Jiuan Sheu. (2017) Recent advances in managing and understanding uveitis. F1000Research 6, pages 280.
Crossref
Crossref
Durga S. Borkar, Cindy Ung & Lucia Sobrin. (2017) Sustained Release Corticosteroid Therapy for Noninfectious Uveitis. International Ophthalmology Clinics 57:4, pages 193-202.
Crossref
Crossref
C Fardeau, E Champion, N Massamba & P LeHoang. (2016) Uveitic macular edema. Eye 30:10, pages 1277-1292.
Crossref
Crossref
Claudia Fabiani & Jorge L. Alió. (2015) Local (topical and intraocular) therapy for ocular Adamantiades−Behçetʼs disease. Current Opinion in Ophthalmology 26:6, pages 546-552.
Crossref
Crossref
C. Fardeau, E. Champion, N. Massamba & P. LeHoang. (2015) Œdème maculaire au cours des uvéites. Journal Français d'Ophtalmologie 38:1, pages 74-81.
Crossref
Crossref
Lazha Talat, Filis Ismetova, Susan Lightman & Oren Tomkins-Netzer. 2015. Intravitreal Steroids. Intravitreal Steroids
81
90
.